Ignite Creation Date:
2025-12-26 @ 10:46 PM
Ignite Modification Date:
2025-12-26 @ 10:46 PM
Study NCT ID:
NCT00968812
Status:
COMPLETED
Last Update Posted:
2017-01-30
First Post:
2009-08-28
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
CANagliflozin Treatment And Trial Analysis-Sulfonylurea (CANTATA-SU) SGLT2 Add-on to Metformin Versus Glimepiride
Sponsor:
Janssen Research & Development, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-09
Start Date Type:
None
Primary Completion Date:
2011-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-01
Completion Date Type:
ACTUAL
First Submit Date:
2009-08-28
First Submit QC Date:
None
Study First Post Date:
2009-08-31
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-04-17
Results First Submit QC Date:
None
Results First Post Date:
2013-06-04
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2012-07-02
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2016-12-01
Last Update Post Date:
2017-01-30
Last Update Post Date Type:
ESTIMATED